CABG Beats DES In SYNTAX Trial; Observers Expect Little Change In Practice
This article was originally published in The Gray Sheet
Executive Summary
Analysts and physicians predict one-year results from the SYNTAX trial will have little short-term impact on demand for drug-eluting stents, even though the devices performed worse than coronary artery bypass graft (CABG) surgery in this seminal randomized trial
You may also be interested in...
Large ASCERT Observational Study Favors CABG Over PCI
Bypass graft surgery had a relative risk reduction of about 20% long term compared to stenting.
PCI Versus CABG: Comparative Effectiveness Study Funded By ARRA Grant
The American College of Cardiology and Society of Thoracic Surgeons will study the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass graft surgery with a $4 million NIH research grant, announced Oct. 2
PCI Versus CABG: Comparative Effectiveness Study Funded By ARRA Grant
The American College of Cardiology and Society of Thoracic Surgeons will study the comparative effectiveness of percutaneous coronary intervention and coronary artery bypass graft surgery with a $4 million NIH research grant, announced Oct. 2